ArticlePeerJ2026
Proteome-wide analysis by liquid chromatography tandem mass spectrometry reveals the role of retinoic acid during adipogenesis in human bone mesenchymal stem cells.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Retinoic acid (RA), an active metabolite of vitamin A, may regulate adipogenesis and is associated with osteoporosis. To clarify the regulatory mechanism of RA in adipogenesis and its relationship with the occurrence and development of osteoporosis, we investigated the role of all-trans retinoic acid (ATRA) in protein expression profiling during human bone mesenchymal stem cells (hBMSCs) adipogenesis. Methods: Liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to determine the protein profile, and raw data were analyzed against the UniProt database using MaxQuant with the Andromeda search engine. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases were used for functional annotation of differentially expressed proteins (DEPs). The interaction relationships of DEPs were assessed using the STRING database, and Cytoscape was used to visualize the protein interaction network. Results: A total of 5,611 proteins were identified by LC-MS/MS in 15 samples, of which 5,470 proteins showed quantifiable data. When treated with ATRA for seven and 14 days after adipogenic induction, 470 and 1,408 DEPs were upregulated and 508 and 1,345 DEPs were downregulated. Gene functional annotation of DEPs showed that ATRA upregulated classic signaling pathways, such as Wnt, Hippo, and MAPK, as well as cytoskeleton related pathways, including focal adhesion, extracellular matrix (ECM)-receptor interaction, and the regulation of actin cytoskeleton. ATRA downregulated many pathways related to metabolism, including the AMP-activated protein kinase (AMPK) and peroxisome proliferator activated receptor (PPAR) pathways, to repress adipocyte differentiation and lipid accumulation. Specifically, the inhibition of adipogenesis by ATRA was significantly attenuated when the Rho-associated protein kinase (ROCK) inhibitor Y27632 was used to block the regulation of actin cytoskeleton pathways. Conclusion: Our study suggests that ATRA downregulates metabolism-related pathways to inhibit the adipogenesis of hBMSCs by upregulating some classic signaling pathways and cytoskeleton-related pathways, indicating that ATRA may be a broad-spectrum metabolic inhibitor.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.